Results 11 to 20 of about 12,555 (213)
Fluconazole-Induced Fixed Drug Eruption With Cross-Reactivity to Clotrimazole-Confirmation With Patch Testing. [PDF]
Case Rep Dermatol MedFirst described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29‐year‐old female who presented after her third episode of an itchy, oedematous, blistering ...
Sron DS +4 more
europepmc +2 more sources
Vaginal yeasts in the era of "over the counter" antifungals [PDF]
, 2000 OBJECTIVE: To establish whether there has been any rise in the prevalence of non-albicans Candida species isolated from vaginal swabs since the introduction of “over the counter” antifungal treatments.
Ashbee, H.R. +4 more
core +8 more sources
Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran [PDF]
International Journal of Fertility and Sterility, 2009 Background Vulvovaginal candidiasis is the most common fungal disease in sexually active women of which Candida albicans is the primary etiologic agent. Materials and methods This cross-sectional study was performed to determine the etiologic agents of
Seddigheh Esmaeilzadeh +2 more
doaj +1 more source
An investigation into the pathogenesis of vulvo-vaginal candidosis [PDF]
, 2001 OBJECTIVE: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. METHODS:Women presenting at the genitourinary medicine clinic with
Ashbee, H.R. +4 more
core +2 more sources
Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns
Folia Medica, 2016 Vulvovaginal candidiasis is the second most common cause of vaginitis worldwide (after bacterial candidiasis). Maternal vulvovaginal candidiasis is a major risk factor for Candida colonization and infection of the infant where prognosis depends on ...
Zisova Liliya G. +8 more
doaj +1 more source
Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. [PDF]
, 2014 BACKGROUND: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at ...
Buffler, Patricia A, Rathod, Sujit D
core +1 more source
Dapagliflozin-Induced Vulvovaginitis in an Atopic Patient with Type 2 Diabetes Mellitus
Endocrinology Research and Practice, 2018 Dapagliflozin, an oral anti-diabetic agent, is a recently discovered sodium-glucose co-transporter receptor-2 inhibitor, which improves glycemic control by facilitating the renal excretion of glucose.
Narin NASIROĞLU İMGA +2 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2017 Aim - to determine population levels of main microbiota and yeast-like fungi of the genus Candida in healthy women and in women with vulvovaginal candidiasis. Materials and methods. For 10 years we have been surveyed 270 women in reproductive age from
N. D. Yakovychuk +5 more
doaj +1 more source
Pathogens, 2023 Epidemiological data on women suffering from vulvovaginal candidiasis and its recurrence are outdated and vague. The aim of this study was to identify the prevalence of women diagnosed with vulvovaginal candidiasis, as well as the epidemiological profile
Encarnación Martínez-García +6 more
doaj +1 more source
Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors [PDF]
, 2016 Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. Although Candida albicans is the main cause of VVC, the identification of non-Candida albicans Candida (NCAC) species, especially Candida ...
Alves, Carlos +5 more
core +1 more source